Skip to main content
Clinical Trials/ACTRN12623001066673
ACTRN12623001066673Not yet recruitingUnknown

Validation of blood pressure monitoring using the Biobeat wireless chest monitor, compared to standard monitoring, in patients in the perioperative period.

Peter MacCallum Cancer Centre0 sites40 target enrollmentStarted: October 5, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
50 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • Setting 1: Included in the Prehabilitation Service at the PMCC with an M-DASI > 3 (modified duke activity score index) .
  • Setting 2: Scheduled to have any surgery greater than one-hour duration with anticipated need for vasopressor drugs perioperatively and monitored in the 23-hour unit on a regular monitored schedule for 24 hours post-operatively.

Exclusion Criteria

  • Exclusion Criteria for Setting 1:
  • Unable to sit on an exercise bike and maintain cadence.
  • Contra-indications to Cardiopulmonary Exercise Test (CPET)
  • Cardiac Rhythm abnormality including the presence of AF
  • Allergy to adhesive tapes and dressings
  • Exclusion Criteria for Setting 2:
  • Surgery is planned to be less than one-hour duration or greater than 4 hours duration.
  • Planned Intensive Care or High Dependency Unit admission post-operatively
  • Less than one overnight stay in hospital
  • Allergy to adhesive tapes and dressings

Investigators

Sponsor
Peter MacCallum Cancer Centre

Similar Trials